Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

Below are the newest and most recently updated Shortage and Discontinuation reports.

Drug pills

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
NEXIUM - 20MG ASTRAZENECA CANADA INC Anticipated shortage 20MG Updated Report 2021-01-26 131188
ACYCLOVIR SODIUM INJECTION PFIZER CANADA ULC Anticipated shortage 25MG Updated Report 2021-01-26 130355
DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML PFIZER CANADA ULC Anticipated shortage 150MG Updated Report 2021-01-26 131489
DEPO-PROVERA STERILE AQUEOUS SUSPENSION 150 MG/ML PFIZER CANADA ULC Anticipated shortage 150MG Updated Report 2021-01-26 131486
FOLIC ACID INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 5MG Updated Report 2021-01-26 107559
SODIUM BICARBONATE INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 42MG Updated Report 2021-01-26 124369
CLADRIBINE INJECTION FRESENIUS KABI CANADA LTD Resolved 1MG Updated Report 2021-01-26 127210
MAGNESIUM SULFATE INJECTION FRESENIUS KABI CANADA LTD Resolved 500MG Updated Report 2021-01-26 127839
POTASSIUM PHOSPHATES INJECTION, USP FRESENIUS KABI CANADA LTD Resolved 224MG 236MG Updated Report 2021-01-26 124366
VASOPRESSIN INJECTION FRESENIUS KABI CANADA LTD Resolved 20UNIT Updated Report 2021-01-26 121651

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
DDAVP RHINYLE FERRING INC To be discontinued 0.1MG New Report 2021-01-26 132472
APO-CELECOXIB APOTEX INC Discontinued 200MG Updated Report 2021-01-21 60366
IMURAN ASPEN PHARMACARE CANADA INC. To be discontinued 50MG Updated Report 2021-01-21 128667
INVIRASE HOFFMANN-LA ROCHE LIMITED Discontinued 500MG New Report 2021-01-20 132101
HUMATROPE ELI LILLY CANADA INC Discontinued 1MG Updated Report 2021-01-18 106800